Provided by Tiger Trade Technology Pte. Ltd.

MGC PHARMACEUTICALS LTD

0.475
0.000
Volume:- -
Turnover:1.31K
Market Cap:2.10M
PE:-0.07
High:0.475
Open:0.475
Low:0.475
Close:0.475
52wk High:1.000
52wk Low:0.410
Shares:4.43M
Float Shares:3.92M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.100
EPS(LYR):-7.066
ROE:--
ROA:-66.72%
PB:-0.28
PE(LYR):-0.07

Loading ...

Company Profile

Company Name:
MGC PHARMACEUTICALS LTD
Exchange:
ASX
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. The company also provides ArtemiC range of products and cannabinoid products, as well as non-pharma products. In addition, it offers consulting services, including clinical research services. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is based in West Perth, Australia.